ArticleFrontiers in oncology2022

Case report: Different mechanisms of drug resistance in a synchronous multiple primary lung cancer patient after EGFR-TKI treatment.

Shaonan Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.